Study of SPARC1103 in Subject With Spasticity

Trial Profile

Study of SPARC1103 in Subject With Spasticity

Phase of Trial: Phase II

Latest Information Update: 07 Feb 2018

At a glance

  • Drugs Baclofen (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Sponsors Sun Pharma Advanced Research Company
  • Most Recent Events

    • 02 Feb 2018 Status changed from active, no longer recruiting to completed.
    • 23 May 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
    • 23 May 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top